{
    "2019-06-26": [
        [
            {
                "time": "2019-06-26",
                "original_text": "AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Allergan",
                        "Botox",
                        "Deal"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "AbbVie Is 'The New Cash King' As It Takes On Botox-Maker Allergan",
                "features": {
                    "keywords": [
                        "Cash King",
                        "Botox",
                        "Allergan"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "AbbVie to Buy Allergan: Prescribed ETFs",
                "features": {
                    "keywords": [
                        "Buy",
                        "Allergan",
                        "ETFs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "ETFs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "AbbVie to Acquire Allergan in Nearly $62B Cash & Stock Deal",
                "features": {
                    "keywords": [
                        "Acquire",
                        "Allergan",
                        "$62B"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "Here's Why Nobody's Happy About This $63 Billion Buyout",
                "features": {
                    "keywords": [
                        "$63 Billion",
                        "Buyout",
                        "Unhappy"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "Big Pharma Has to Bet Big on M&A. Investors Donâ€™t.",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "M&A",
                        "Investors"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "Health Care Sector Update for 06/26/2019: ACST, ABBV, EYEG, NBRV, AGN, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "ACST",
                        "ABBV",
                        "AGN"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "health care"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}